Echo Therapeutics Inc (ECTE.OQ)

ECTE.OQ on NASDAQ Stock Exchange Capital Market

0.49USD
21 May 2013
Price Change (% chg)

$-0.00 (-1.02%)
Prev Close
$0.49
Open
$0.49
Day's High
$0.54
Day's Low
$0.48
Volume
72,891
Avg. Vol
51,298
52-wk High
$2.00
52-wk Low
$0.19

ECTE.OQ

Chart for ECTE.OQ

About

Echo Therapeutics, Inc. (Echo) is a transdermal medical device company. The Company is developing Prelude SkinPrep System (Prelude) as a technology to allow for painless and skin permeation that enable both needle-free drug delivery and analyte extraction. Utilizing this technology, the Company is developing its needle-free... (more)

Overall

Beta: 0.42
Market Cap (Mil.): $28.92
Shares Outstanding (Mil.): 60.24
Dividend: --
Yield (%): --

Financials

  ECTE.OQ Industry Sector
P/E (TTM): -- 76.89 35.85
EPS (TTM): -0.31 -- --
ROI: -89.76 4.21 18.76
ROE: -90.88 9.05 19.57
Search Stocks

Competitors

  Price Change
Abbott Laboratories (ABT.N) $37.72 -0.09
Medtronic, Inc. (MDT.N) $52.35 +2.46
Edwards Lifesciences Corp (EW.N) $66.00 -0.37
DexCom, Inc. (DXCM.OQ) $21.13 -0.11
Johnson & Johnson (JNJ.N) $88.59 +0.58

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Thomson Reuters Stock Report - ECHO THERAPEUTICS INC. (ECTE-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
ECHO THERAPEUTICS INC (ECTE) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy
Echo Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
ValuEngine Detailed Valuation Report for ECTE
Provider: ValuEngine, Inc.
$127.00
Buy
Echo Therapeutics, Inc. (ECTE) - Financial and Strategic SWOT Analysis Review
Provider: GlobalData
$125.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks